how is retatrutide different from tirzepatide for weight loss: Study shows 30% body weight loss Retatrutide vs. Tirzepatide: The Next-Gen

The hospital pharmacies segment is projected to dominate the market during the forecast period owing to the large distribution of Glp-1 analogues in the hospital pharmacy setup for inpatients

FDA sends warning letter to maker of Ozempic, Wegovy over unreported potential GLP-1 side effects The U.S

Weight gain only creates more inflammation and leads to further depression

GLP-1 drugs have dramatically higher success rates for significant weight loss than a traditional diet plan alone

For this reason, it became a drug to treat type 2 diabetes

Oral dual GLP-1/GIP agonists and oral GLP-1/glucagon agonists are in preclinical and early clinical development at several pharmaceutical companies